Kubat Compounding

Kubat Compounding is a pharmacy in Omaha, NE. The business has been compounding prescription-based medications since 1935 and serves patients in Omaha and across multiple states. Its work centers on preparing customized formulations when commercially available medications are not the right fit, collaborating with prescribers to address specific dosage, strength, and ingredient needs. Service areas include dermatology, women's health, men's health, weight management, pain management, nutritional supplements, low dose naltrexone, and veterinary compounding.

The pharmacy brings more than 90 years of compounding experience to its work, with pharmacists who prepare patient-specific prescriptions in collaboration with healthcare providers. As a PCCA member, Kubat Compounding has access to thousands of reviewed formulations and works with prescribers to develop customized medications when standard options fall short. The pharmacy follows USP 795, USP 797, and USP 800 standards for non-sterile and sterile compounding, with documented quality checks, USP-grade chemicals, and precise compounding equipment supporting patient safety and consistency. Pricing and options are reviewed with patients before compounding begins, and the team contacts patients within 24 business hours of receiving a prescription to discuss next steps, shipping, and any questions.

In women's health, pharmacists with specialized training in bio-identical hormone replacement therapy prepare custom medications structurally identical to natural hormones, including estrogens, progesterone, testosterone, and DHEA, available in capsules, creams, gels, suppositories, and troches. The pharmacy also supports men's health concerns such as testosterone replacement, andropause, erectile dysfunction, low libido, and aches and pains through individualized formulations. Dermatologic compounding allows providers to adjust strengths, combine active ingredients, select alternative bases, and address ingredient sensitivities for personalized skin care plans.